Effect of anti-GM-CSF treatment prior to the onset of arthritis

Copyright information:

Taken from "Blockade of collagen-induced arthritis post-onset by antibody to granulocyte-macrophage colony-stimulating factor (GM-CSF): requirement for GM-CSF in the effector phase of disease"

Arthritis Research 2001;3(5):293-298.

Published online 11 Jun 2001

PMCID:PMC64841.

Copyright © 2001 Cook et al, licensee BioMed Central Ltd

Severity (mean clinical scores ? SEM). Cumulative incidence. Mice were treated intraperitoneally every second day from days 21 to 31 with anti-GM-CSF mAb or control mAb. = 0.05 and = 0.01 compared with control mAb-treated. GM-CSF, Granulocyte macrophage-colony stimulating factor; mAb, monoclonal antibody.